Loading...
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

PropertyValue
has major subject area list Antibodies, Monoclonal; Antiviral Agents; Immunocompromised Host; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin

Search Criteria
  • Infections
  • immunocompromised hosts